JP2023527612A5 - - Google Patents
Info
- Publication number
- JP2023527612A5 JP2023527612A5 JP2022551351A JP2022551351A JP2023527612A5 JP 2023527612 A5 JP2023527612 A5 JP 2023527612A5 JP 2022551351 A JP2022551351 A JP 2022551351A JP 2022551351 A JP2022551351 A JP 2022551351A JP 2023527612 A5 JP2023527612 A5 JP 2023527612A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pain
- cbga
- immune cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062981424P | 2020-02-25 | 2020-02-25 | |
| US62/981,424 | 2020-02-25 | ||
| US202063072806P | 2020-08-31 | 2020-08-31 | |
| US63/072,806 | 2020-08-31 | ||
| PCT/US2021/019474 WO2021173718A1 (en) | 2020-02-25 | 2021-02-24 | Cannabinoid compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527612A JP2023527612A (ja) | 2023-06-30 |
| JP2023527612A5 true JP2023527612A5 (cg-RX-API-DMAC7.html) | 2024-03-04 |
Family
ID=77490171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551351A Pending JP2023527612A (ja) | 2020-02-25 | 2021-02-24 | カンナビノイド組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230091336A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4110045A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023527612A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021227227A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3172868A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021173718A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202101732D0 (en) * | 2021-02-08 | 2021-03-24 | Tts Pharma Ltd | A cannabinoid mixture |
| WO2023064478A1 (en) * | 2021-10-13 | 2023-04-20 | Portland Technology Holdings Llc | Hemp extract for treatment of pain, cancer and epilepsy in animals |
| US12440454B2 (en) | 2022-02-01 | 2025-10-14 | Portland Technology Holdings Llc | Pharmaceutical compositions containing hemp extract for administration to felines and related methods |
| WO2026038872A1 (ko) * | 2024-08-13 | 2026-02-19 | 주식회사 네오켄바이오 | 신규한 화합물 및 이의 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1559423A1 (en) * | 2004-02-02 | 2005-08-03 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Medicinal acidic cannabinoids |
| GB2527590A (en) * | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
| JP7225104B2 (ja) * | 2017-02-01 | 2023-02-20 | ジービーエス グローバル バイオファーマ,インコーポレイテッド | マスト細胞関連炎症障害又は好塩基球媒介炎症障害の治療のためのカンナビノイド含有複合混合物 |
| WO2018163164A1 (en) * | 2017-03-05 | 2018-09-13 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Compositions and methods for treating cancer |
| JP2020520966A (ja) * | 2017-05-22 | 2020-07-16 | ジービーエス グローバル バイオファーマ,インコーポレイテッド | Trpv1を標的にするミルセン及びカンナビノイド含有組成物 |
| WO2019071302A1 (en) * | 2017-10-09 | 2019-04-18 | The University Of Sydney | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING EPILEPSY CRISES |
| US10751380B2 (en) * | 2018-03-08 | 2020-08-25 | Alexander Kariman | Compound and method for treating spasms, inflammation and pain |
| CA3096842A1 (en) * | 2018-04-09 | 2019-10-17 | Ellevet Sciences | Hemp extract for treatment of pain in animals |
| CN112543633A (zh) * | 2018-05-22 | 2021-03-23 | Gbs全球生物制药公司 | Trpv1调节中使用的大麻素和/或萜烯 |
| EP3813823A4 (en) * | 2018-06-28 | 2022-08-10 | Canopy Growth Corporation | COMPOSITIONS AND METHODS FOR AGONIZING THE CB2 RECEPTOR |
-
2021
- 2021-02-24 JP JP2022551351A patent/JP2023527612A/ja active Pending
- 2021-02-24 CA CA3172868A patent/CA3172868A1/en active Pending
- 2021-02-24 US US17/904,934 patent/US20230091336A1/en not_active Abandoned
- 2021-02-24 WO PCT/US2021/019474 patent/WO2021173718A1/en not_active Ceased
- 2021-02-24 AU AU2021227227A patent/AU2021227227A1/en not_active Abandoned
- 2021-02-24 EP EP21760253.1A patent/EP4110045A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ARAKAWA et al. | Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing | |
| Henrotin et al. | Natural products for promoting joint health and managing osteoarthritis | |
| Selim et al. | Fucoidan mitigates gastric ulcer injury through managing inflammation, oxidative stress, and NLRP3-mediated pyroptosis | |
| Ordooei Javan et al. | A review on colistin nephrotoxicity | |
| Morgera et al. | Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure | |
| Zhou et al. | Curcumin inhibits placental inflammation to ameliorate LPS-induced adverse pregnancy outcomes in mice via upregulation of phosphorylated Akt | |
| US20050147675A1 (en) | Composition for the treatment and prevention of endothelial dysfunction | |
| Gunasekaran et al. | Hyaluronan 35 kDa enhances epithelial barrier function and protects against the development of murine necrotizing enterocolitis | |
| Ma et al. | Thiamine alleviates high-concentrate-diet-induced oxidative stress, apoptosis, and protects the rumen epithelial barrier function in goats | |
| Bak et al. | Effects of dietary supplementation of glucosamine sulfate on intestinal inflammation in a mouse model of experimental colitis | |
| KR20190095937A (ko) | 설페이트화된 다당류를 포함하는 조성물 | |
| Wang et al. | Florfenicol induces renal toxicity in chicks by promoting oxidative stress and apoptosis | |
| Zhou et al. | Supplementation of the diet with Salecan attenuates the symptoms of colitis induced by dextran sulphate sodium in mice | |
| Raj et al. | The effects of oat ingredients on blood pressure in spontaneously hypertensive rats | |
| Motavallian et al. | An investigation of the anti-inflammatory effects of gabapentin on acetic acid-induced colitis in rats | |
| AU2025234176A1 (en) | Treatment for Coronavirus infection and associated cytokine toxicity | |
| Li et al. | Simvastatin attenuates acute lung injury by activation of A2B adenosine receptor | |
| Kim et al. | BN82002 alleviated tissue damage of septic mice by reducing inflammatory response through inhibiting AKT2/NF-κB signaling pathway | |
| JP2022521711A5 (cg-RX-API-DMAC7.html) | ||
| US20120244226A1 (en) | Treatment composition and method | |
| WO2021195691A1 (en) | Methods and compositions for treating or preventing an inflammatory condition | |
| Ecelbarger et al. | The effect of chronic candesartan therapy on the metabolic profile and renal tissue cytokine levels in the obese Zucker rat | |
| Cahyawati | Effect of simvastatin on histopathology of the heart after 5/6 subtotal nephrectomy | |
| US20240050455A1 (en) | Methods of treatment of a cytokine storm | |
| Yao et al. | Peroxisome proliferator-activated receptor-γ agonists diminish peritoneal functional and morphological changes induced by bioincompatible peritoneal dialysis solution |